Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. EPIDUO FORTE GEL 0.3%/2.5% [SIN15460P]

EPIDUO FORTE GEL 0.3%/2.5% [SIN15460P]

Active ingredients: EPIDUO FORTE GEL 0.3%/2.5%

Last updated 26 October 2025

On this page

Product Info
CONTRAINDICATIONS

Product Info

EPIDUO FORTE GEL 0.3%/2.5%

[SIN15460P]

Product information

Active Ingredient and Strength

ADAPALENE - 0.3% W/W
BENZOYL PEROXIDE - 2.5% W/W

Dosage Form

GEL

Manufacturer and Country

G PRODUCTION INC - CANADA
LABORATOIRES GALDERMA - FRANCE

Registration Number

SIN15460P

Licence Holder

GALDERMA SINGAPORE PRIVATE LIMITED

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

D10AD53

INDICATIONS AND CLINICAL USE
EPIDUO FORTE Gel (adapalene 0.3%/benzoyl peroxide 2.5%) is indicated for:

  • Treatment of acne vulgaris, characterized by comedones, inflammatory papules/pustules with or without occasional nodules in patients 12 years of age and older. (See Clinical Trials Section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)

DOSAGE AND ADMINISTRATION
Recommended Dose and Dosage Adjustment

EPIDUO FORTE Gel (adapalene 0.3%/benzoyl peroxide 2.5%) Gel (patients 12 years of age and older), should be applied to affected areas of the face, chest and back once daily in the evening, after washing gently with a non-medicated cleanser.

A small amount of EPIDUO FORTE Gel should be applied to provide a thin film, avoiding eyes, lips and mucous membranes. This medication should not be applied to cuts, abrasions, eczematous, or sunburned skin.

If irritation occurs, the patient should be directed to apply non-comedogenic moisturizers. Discontinue treatment if a severe local inflammatory response is experienced. Reinstitute therapy when the reaction has subsided, initially applying the preparation less frequently (e.g. every other day). Once-daily application may be resumed if it is judged that the patient is able to tolerate the treatment.

Missed Dose
If a single dose is missed, dosing should continue as per usual the following day, and the usual amount should be applied.

CONTRAINDICATIONS

  • Patients who are hypersensitive to adapalene, benzoyl peroxide or to any ingredient in the formulation or component of the container. For a complete listing, see the DOSAGE FORMS, COMPOSITION AND PACKAGING section – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.

  • Application to areas of skin affected by eczema or seborrhoeic dermatitis

  • Pregnancy

  • Women planning a pregnancy